HCG Administration involves the therapeutic delivery of Human Chorionic Gonadotropin, a hormone structurally similar to LH, typically via injection to stimulate endogenous androgen production. In men, this is utilized to support testicular function and testosterone synthesis, effectively signaling the gonads directly. This intervention is a targeted method for modulating the HPG axis.
Origin
The hormone’s initial context was pregnancy diagnosis, but its therapeutic use in endocrinology arose from recognizing its ability to mimic Luteinizing Hormone (LH) action on Leydig cells. The term signifies a specific pharmacological strategy aimed at stimulating the testes when endogenous LH signaling is insufficient or suppressed. It is rooted in reproductive endocrinology.
Mechanism
When administered, HCG binds to LH receptors on testicular Leydig cells, triggering the synthesis and release of testosterone, thereby maintaining androgenic support independent of pituitary signaling. This mechanism is often employed during or after the cessation of exogenous androgen use to ‘wake up’ suppressed testicular function. Protocol adherence is essential for maintaining feedback sensitivity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.